Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GiSAS: Aripiprazole, Olanzapine, and Haloperidol in Schizophrenia
NCT01052389Phase 4Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Jul 2007
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole in schizophrenia, sponsored by Mario Negri Institute for Pharmacological Research. Started Jul 2007; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01052389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01052389.